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Abstract
Background: The aim of this study is evaluating the (cost-) effectiveness of a multidisciplinary, evidence based
care program to improve the management of depression in nursing home residents of somatic and dementia
special care units. The care program is an evidence based standardization of the management of depression,
including standardized use of measurement instruments and diagnostical methods, and protocolized psychosocial,
psychological and pharmacological treatment.
Methods/Design: In a 19-month longitudinal controlled study using a stepped wedge design, 14 somatic and 14
dementia special care units will implement the care program. All residents who give informed consent on the
participating units will be included. Primary outcomes are the frequency of depression on the units and quality of
life of residents on the units. The effect of the care program will be estimated using multilevel regression analysis.
Secondary outcomes include accuracy of depression-detection in usual care, prevalence of depression-diagnosis in
the intervention group, and response to treatment of depressed residents. An economic evaluation from a health
care perspective will also be carried out.
Discussion: The care program is expected to be effective in reducing the frequency of depression and in
increasing the quality of life of residents. The study will further provide insight in the cost-effectiveness of the care
program.
Trial registration: Netherlands Trial Register (NTR): NTR1477
Background
Depression is a common health problem in nursing
home (NH) residents: prevalence rates vary from 6 to
even 50% [1-3]. Depression is strongly related to quality
of life of NH residents [4], it seriously impacts wellbeing
and daily functioning, and increases use of health care
services and even mortality [5-7]. The association
between depression and quality of life highlights the
importance of identifying and treating depression in NH
residents with and those without dementia [8,4].
Unfortunately, although depression is a treatable disor-
der [9], various studies have shown poor detection and
undertreatment of depression in NH residents [2,10-12].
Several studies have demonstrated effects of pharma-
cological and psychosocial interventions for depression
in nursing homes [13,14]. The review of Bharucha et al.
[15] of ‘talk therapies’ f o rd e p r e s s i o ni nl o n g - t e r mc a r e
presents evidence for an improvement in depressive
symptoms after reminiscence/life review therapy. More-
over, there is evidence for the effectiveness of multifa-
ceted interventions in residential care [16-18] and in
nursing homes [19,20].
The Nijmegen UniversityN HN e t w o r k( U K O N ) ,a
collaboration between 12 care organizations and the
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Radboud University Nijmegen Medical Centre, has
developed the care program Act In case of Depression
(AID), a multidisciplinary care program to identify and
treat depression and monitor treatment effects. The care
program is based on and in accordance with the recom-
mendations as formulated in the Supplement Older
Adults of the multidisciplinary evidence based guideline
for diagnosis and treatment of depression [21] and the
Consensus Statement of the American Geriatrics Society
and the American Association of Geriatric Psychiatry
[22]. The care program is an implementable plan of
work that coordinates how the different disciplines
should work together, fits in daily practice, and
describes how new working methods are related to and
can be integrated in the present care process following a
step-by-step plan [23].
To date, cost effectiveness studies into the manage-
ment of depression in NH have not been carried out,
but are requested [24]. Gruber-Baldini et al. [10] did
find increased involvement of mental health profes-
sionals in depressed long-term care residents with
dementia, and Smalbrugge et al. [6] found that
depressed residents of somatic units had increased use
of medication, and received medical specialist consulta-
tion and treatment more often than non-depressed resi-
dents, implying expensive medical tests and hospital
admissions. This paper describes a study that will evalu-
ate the cost effectiveness of the care program AID.
Methods/Design
The study is a stepped wedge, multicentre intervention
study on 14 somatic and 14 Dementia Special Care
(DSC) units of UKON-NH.
A stepped wedge design is a type of crossover design
in which different clusters (here: units) cross over from
the control group to the intervention group at different
time points. All clusters are measured at each time
point. The first time point corresponds to a baseline
measurement where none of the clusters receive the
intervention of interest; at the last time point all clusters
receive the intervention. After intermediate time points,
clusters initiate the intervention. More than one cluster
may start the intervention at a time point, but the time
a cluster begins the intervention is randomized [25] (see
Figure 1 for a graphical representation of the design).
This way, comparisons within units ánd between units
will be available, making the design very powerful.
Another advantage of the design is that all involved
units will receive the intervention - which is expected to
increase motivation for participating in the study.
At the start of the data collection, the residents with
informed consent of all 28 units are screened for
depression (T0). Following this, each of the units is
randomly assigned to one of 5 groups. Each group starts
the intervention at different time points, directly after
one of the measurements (T0-T4), which are each 4
months apart. In the four- month interval between T0
and T1, nursing staff of the first group is trained within
the first month. After this month, the intervention runs
for the subsequent 3 months in the first group before
the second measurement (T1) of all 28 units takes place.
After T1, the second group is trained, and the interven-
tion starts in this group while it is continued in the first
group. This procedure is repeated for the remaining 3
groups until, at the last measurement (T5), all 28 units
are in the intervention condition. Consequently, the fol-
low up in the intervention condition varies from 3
months for the last group, which starts with the inter-
vention 1 month after T4, to 19 months for the first
group, which starts after T0.
Intervention
Figure 2 shows the care program AID. AID proposes an
evidence and practice based standardization of 5 compo-
nents in the management of depression: 1) identification
of depressive symptoms, 2) screening, 3) diagnosis, 4)
treatment and 5) monitoring. AID includes standardized
use of measurement instruments and diagnostical meth-
ods, and protocolized treatment that combines psycho-
social, psychological and pharmacological interventions.
Cooperation between the disciplines is prearranged. As
the ability of nursing staff to detect depression can and
should be enhanced [26], the multifaceted and multidis-
ciplinary care program ‘AID’ starts with a training pro-
gram for nursing staff on how to identify symptoms of
depression using a short observation scale [27] and how
to support NH residents with depressive symptoms or
Figure 1 Graphical representation of the stepped wedge
design. ‘0’ represents measurement of usual care; control condition
’1’ represents measurement after the intervention has been
implemented; intervention-condition
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the identification, screening, diagnosing, treatment and
monitoring of depression.
Identification
nursing staff completes a short observation scale for
depression [27] for all participating residents on the
unit. If according to the scores on the scale further
screening is indicated, nursing staff contacts the psy-
chologist who takes over the coordination on the
screening and diagnosing. If no further screening is indi-
cated, nursing staff will complete the observation scale
again after 3-4 months.
Screening
The psychologist screens the ‘identified’ residents of
somatic units for depressive symptoms with the GDS-8
(Geriatric Depression Scale-NH version; cut-off score 2/
3) [28] and those of DSC units with the CSDD (Cornell
Scale for Depression in Dementia; cut-off score 7/8)
[29-31]. If screening with the GDS-8 in somatic residents
is problematic because of cognitive or communication
problems, the CSDD will also be administered [32].
For residents with depressive symptoms, i.e. total
scores on the GDS-8 or CSDD above the cut-off score, a
diagnostic procedure will follow. For other residents, the
identification phase will be repeated after 3-4 months.
Diagnosing
The elderly care physician and psychologist of each unit
perform a diagnostic procedure including the use of
chart information, caregiver interview, and examination
of the resident (interview, physical examination). Diag-
nosis of major depression is established according to the
DSM-IV-TR criteria. For minor depression the same
criteria are used while only 2 to 4 symptoms are present
[33,34]. In residents with dementia the Provisional Diag-
nostic Criteria for depression in Alzheimer’s disease are
applied (PDC) [35].
Treatment
Somatic and dementia residents with depressive symp-
toms, but without a clinical diagnosis of depression, are
offered a personal day structure program made by the
nursing staff in collaboration with the recreational
therapist. Exercise and music therapy can be part of this
day program. Psycho-education is also offered to the
resident and/or relatives, including information about
depressive symptoms and coping strategies.
Somatic residents with minor depression receive the
same treatment as residents with depressive symptoms
extended with individual life review therapy. This ther-
apy is based on a protocol that has already been used
successfully in Dutch residential care residents and is
developed in close collaboration with the Dutch life
review expert E. Bohlmeijer [36].
Somatic residents with major depressive disorder
receive the same treatment as residents with minor
depression extended with pharmacological treatment,
when deemed appropriate by the elderly care physician.
Prescription of pharmacological therapy is in accordance
with the recommendations of the Supplement Older
Adults [21].
For dementia residents with a PDC-depression diagno-
sis, treatment includes a personal day structure program,
a behavioral management strategy developed by the psy-
chologist and psycho education - especially of relatives.
Apart from that, psychological treatment is offered: the
clinical experts involved in the development of this care
program agreed with recommendations made in the
Supplement Older Adults [21] to intervene through the
nursing staff (mediative therapy), but stressed that indi-
vidual contact with the resident is also a necessity.
Thus, for dementia residents, psychological treatment
comprises of the psychologist supporting and supervis-
ing the nursing staff and recreational therapist more
intensively in their execution of the day structure pro-
gram and behavioral management strategy. This support
takes place in a regular staff meeting, every two weeks.
Within 1 month after the diagnosis, the day structure
program and behavioral management strategy should be
incorporated in regular care. The psychologist supervises
the recreational therapist and nursing staff in at least 2
regular staff meetings. Additionally, if the depression in
dementia residents is severe, pharmacological therapy
can be given by the elderly care physician, when deemed
appropriate.
Monitoring
Monitoring with a validated measurement instrument
takes place to evaluate treatment. For this purpose, the
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Figure 2 Graphical representation of the AID care program.
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used in dementia residents.
Sampling
We calculated the sample-size using the following
assumptions.
For somatic units: 25 residents per unit [37], a depres-
sion prevalence of 22% [38], a remission rate of 40%
[39], and an attrition of 20% [38].
For DSC units: 20 residents per unit [40], a depression
prevalence of 30% [10,40-42], a remission rate of 35%
[13], and negligible attrition [40].
Based on these assumptions and a significance level
alpha of 0.05, a power of 0.80 and an ICC of 0.1 for
both somatic and dementia residents, 14 clusters (units)
with 6 measurements are needed in a stepped wedge
design to allow multilevel analysis.
Given that the outcomes will be presented on unit-
level, during the data collection, newly admitted resi-
dents and/or their legal representatives are asked to pro-
vide informed consent on all units. This way, the sample
size is not influenced by death or relocation of partici-
pating residents and can remain stable.
Ethical approval
The Medical Ethics Committee of the Radboud Univer-
sity Nijmegen Medical Centre (CMO Arnhem-Nijme-
gen) rated the study and pronounced that it is not
burdensome for the participant. Each NH resident and/
or the legal representative on the participating units
receives written and verbal information prior to the AID
study and is only included in the study after having
given written informed consent.
Measurements
Primary outcomes are frequency of depression and qual-
ity of life.
Frequency of depression (the percentage of residents
with depression on a unit) is measured in somatic resi-
dents by a shortened version of the Geriatric Depression
Scale (GDS)[43], the 8-item GDS-nursing home version
(GDS-8) of Jongenelis et al. [28], which was made by
deleting GDS-items that are not applicable to most NH
residents. The GDS-8 was validated in the AGED data-
set, where it showed a good internal consistency of a =
.80 and high sensitivity rates of 96.3% for major depres-
sion and 83.0% for minor depression, with a specificity
rate of 71.7% at a cut-off score of 3 or more [28]. The
GDS-8 also appears to be able to assess (change in)
severity of depression [44]. The GDS-30 is originally a
self-report instrument, the GDS-8 is interview based.
Frequency of depression in dementia residents is
measured by the Cornell Scale for Depression in
Dementia (CSDD)[29]. The CSDD is administered
through interviewing nursing staff about their observa-
tions of the residents’ behavior. The CSDD consists of
19 items each rated as 0 = absent, 1 = mild or intermit-
tent and 2 = severe. The scores of the individual items
are summed and a cut-off of 8 or more indicates
depression [29]. Vida et al. [30] reported for a cut-off
s c o r eo f8o rm o r e ,as e n s i t i v i ty of 90% and specificity
of 75% in residents with Alzheimer’s Disease.
Quality of life in somatic residents is measured by the
EQ-5D [45]. The EQ-5D instrument is a standardized
non disease-specific instrument for describing and valu-
ing Health Related Quality of Life [46]. There are two
core components of the instrument: a description of the
respondent’s ‘own health’ using a health state classifica-
tion system with five domains (mobility, self-care, usual
activities, pain/discomfort and anxiety/depression) and a
rating of ‘own general health’ by means of a visual ana-
logue ‘thermometer’ scale. The EQ5D has shown a good
validity and good test-retest reliability [47,48].
In dementia residents quality of life is measured by
the EQ-5D proxy version [49]. Thereto, nursing staff are
asked to score the scale for the resident.
Secondary outcomes are percentage accuracy of
depression-detection in usual care, prevalence of depres-
sion-diagnosis in the intervention group, and response
to treatment of depressed residents.
Additional measurements involve measurement of
cognitive functioning by the Mini Mental State Exami-
nation (MMSE) [50] and measurement of sociodemo-
graphic variables, mental health history - including prior
depressive episodes-, present mental health condition -
including a dementia diagnosis -, possible treatment for
depression, and somatic comorbidity.
Measurements are done by the research team. To
study the compliance to the care program, the actual
use of all components of the psychosocial, psychological
and pharmacological treatment, as well as the factors
determining this use, are registered. Accordingly, written
checklists are used for nursing staff, recreational thera-
pist, psychologist and elderly care physician, separately.
Data-analysis
Primary effects will be calculated using multilevel regres-
sion analysis, for somatic and DSC units separately. The
GDS-8-scores and CSDD-scores will be used in the primary
analysis. Age, sex, cultural background and cognitive status
will be used as covariates. The EQ5D will be analyzed as
another primary outcome in the intervention study. For
cost analysis, see economic evaluation. A process analysis
will be carried out to determine the actual use of the com-
ponents of the psychosocial, psychological and pharmacolo-
gical treatment, and to determine facilitators and obstacles.
Secondary outcomes (percentage accuracy of depression-
detection in usual care, prevalence of depression-diagnosis
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depressed residents) will be analyzed using descriptive
statistics.
Economic evaluation
This study investigates the efficiency of the care pro-
gram AID compared to usual care as provided in NH
units. If the program AID turns out to be successful, a
decrease in the prevalence of depression in NH will
occur. On the one hand the program needs investment
in for example training of nursing staff and, conse-
quently, generates extra costs compared to usual care.
On the other hand it potentially generates savings as it
reduces depression related time investment in NH.
The economic evaluation is based on the general prin-
ciples of a cost-effectiveness analysis from a healthcare
viewpoint. Based on the above mentioned primary out-
comes, two different incremental cost effectiveness
ratios (ICERs) will be computed, answering the ques-
tions: ‘How much money has to be invested additionally
in the care program to gain one percentage point
decrease in frequency of depression?’ and ‘How much
money has to be invested additionally in the care pro-
gram to gain one Quality-Adjusted Life Year (QALY)?’
The cost analysis consists of two main parts. First, on
resident level, volumes of care (to determine the incre-
mental direct health care costs) based on the production
process of the care program and of depression decrease
are measured prospectively using an activity based costing
approach. Focusing on activities performed with costs
accumulated at the activity level(s) of the health care pro-
duction processes, standardized case report forms are used
to assess time invested by nursing staff, psychologist,
elderly care physician and recreational therapist. Also,
number of hospital admissions (number of days in hospi-
tal) and use of antidepressant medication are recorded.
Second, the cost prices for each volume of consump-
tion will be determined to use these for multiplying the
volumes registered for each participating resident. The
Dutch guidelines for cost analyses will be used [51]. For
units of care/resources where no guideline or standard
prices are available, real cost prices will be determined.
Statistics of the total costs per resident will be deter-
mined for usual care and care according to the care pro-
gram AID. Depending on the skewness of the parameter
distributions, statistical testing of differences between
strategies will be of a parametrical or non parametrical
nature. The impact of deterministic variables, such as
cost prices for volume parameters that are incremental
cost drivers will be investigated using sensitivity analyses
on the basis of the range of extremes.
The effect analysis adheres to the design of the study.
Relevant for the economic evaluation are the frequency of
depression (measured with GDS-8 and CSDD) and QALYs
(utilities measured with the EQ-5D). Using the trapezium
rule, the QALYs will be computed in order to perform a
cost-effectiveness analysis comparing the two alternative
strategies. Change in utilities (EQ-5D) will be based on the
mean values for the residents when they are in the control
condition and the mean values after having been in the
intervention for 3 (all 5 groups), 7 (4 groups), 11 (3 groups),
15 (2 groups) and 19 months (1 group). ICERs will be com-
puted and sampling uncertainty will be determined using
the bootstrap or Fieller method. Finally, a cost-effectiveness
acceptability curve will be derived that is able to evaluate
efficiency by different thresholds for the ICERs.
Discussion
In this paper we described the design of a randomized
trial to evaluate the (cost-)effectiveness of a multidisci-
plinary, evidence based care program to improve the
management of depression in NH residents of somatic
and DSC units. This study holds several unique elements.
First of all, the Department of Primary and Commu-
nity Medicine of the Radboud University Nijmegen
Medical Centre has established a structural collaboration
with 12 care organizations (representing 40 NH and 100
residential homes) in the Nijmegen University NH Net-
work (UKON). An expert group of the UKON has
developed the care program AID, based on evidence
based guidelines and the Consensus Statements [21,22].
Implementation is expected to be successful, because it
fits with daily practice and describes how new working
methods are related to and can be integrated in the pre-
sent care process following a step-by-step plan [23].
Secondly, the intervention is based on a stepped care
approach: the more serious the depressive complaints or
t h ed e p r e s s i o n ,t h em o r ei n t e n s et h ei n t e r v e n t i o nw i l l
be. The standardized interventions will be tailored to
the needs of the individual resident. This will expectedly
increase its effectiveness and facilitate transferring this
strategy to other nursing homes.
Finally, the design of the study -the stepped wedge
design- is a relatively new design, and has not been
applied before in long term care. Using a stepped wedge
design signifies that all participating units will cross-
over from the control condition to the intervention con-
dition during the study. This is expected to increase the
motivation of NH workers to participate in scientific
research.
In conclusion, the care program is expected to be
effective in reducing the frequency of depression and in
increasing the quality of life of residents. The study also
will provide insight in the program’s cost- effectiveness.
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